Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical College, University of South China, Hengyang, Hunan, China.
Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China.
Dis Markers. 2022 Jul 25;2022:6899777. doi: 10.1155/2022/6899777. eCollection 2022.
Long noncoding RNAs (lncRNAs) are strongly associated with the development of breast cancer (BC). As yet, the function of LINC01234 in BC remains unknown.
Using biological information, the potential lncRNA, miRNA, and target gene were predicted. LINC01234 and miR-525-5p expression in BC tissues was detected using quantitative real-time reverse transcription polymerase chain reaction. Fluorescence in situ hybridization was used to determine the distribution of LINC01234. Cell proliferation was analyzed using CCK-8 assay, colony formation, terminal deoxynucleotidyl transferase dUTP nick end labeling staining, and apoptosis evaluated using flow cytometry. Western blotting was used to evaluate protein expression. Dual-luciferase® reporter, RNA pull-down, and RNA immunoprecipitation assays were performed to analyze the binding relationships among LINC01234, miR-525-5p, and cold shock domain-containing E1 (CSDE1).
We screened out LINC01234, found to be significantly increased in BC tissues, associated with a poor prognosis, and positively correlated with tumor size of BC. Knockdown of LINC01234 suppressed BC cell growth and facilitated apoptosis. Dual-luciferase reporter®, RNA pull-down, and RNA immunoprecipitation assays confirmed that LINC01234 and CSDE1 directly interacted with miR-525-5p. Upregulation of miR-525-5p and suppression of CSDE1 inhibited BC cell growth and induced cell apoptosis.
Upregulation of LINC01234 contributes to the development of BC through the miR-525-5p/CSDE1 axis. LINC01234 may be one of the potential diagnostic and treatment targets for BC.
长链非编码 RNA(lncRNA)与乳腺癌(BC)的发生发展密切相关。然而,LINC01234 在 BC 中的作用尚不清楚。
利用生物信息学方法预测潜在的 lncRNA、miRNA 和靶基因。采用实时定量逆转录聚合酶链反应检测 BC 组织中 LINC01234 和 miR-525-5p 的表达。采用荧光原位杂交技术检测 LINC01234 的分布。采用 CCK-8 assay、集落形成实验、末端脱氧核苷酸转移酶 dUTP 缺口末端标记染色法分析细胞增殖,采用流式细胞术检测细胞凋亡。采用 Western blot 检测蛋白表达。采用双荧光素酶报告基因、RNA 下拉和 RNA 免疫沉淀实验分析 LINC01234、miR-525-5p 和冷休克域包含蛋白 E1(CSDE1)之间的结合关系。
我们筛选出 LINC01234,发现其在 BC 组织中显著上调,与预后不良相关,且与 BC 肿瘤大小呈正相关。敲低 LINC01234 抑制 BC 细胞生长并促进细胞凋亡。双荧光素酶报告基因、RNA 下拉和 RNA 免疫沉淀实验证实 LINC01234 和 CSDE1 可直接与 miR-525-5p 相互作用。上调 miR-525-5p 和抑制 CSDE1 可抑制 BC 细胞生长并诱导细胞凋亡。
LINC01234 的上调通过 miR-525-5p/CSDE1 轴促进 BC 的发生发展。LINC01234 可能是 BC 潜在的诊断和治疗靶点之一。